Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24230MP2011PTC025427 Incorporated 21 February 2011 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹2.69 Cr
▲ 26% YoY
Net profit · FY 2025
₹24.32 Lakh
Net margin 9%
EBITDA · FY 2025
₹37.12 Lakh
EBITDA margin 13.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered

About Andromeda Pharmaceuticals Private Limited

Data last updated:

Andromeda Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 February 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2011PTC025427. Its GSTIN is 23AAJCA2913L1ZS (Madhya Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors including Manoj Mundra and Prem Lata Pandey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.69 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹24.32 Lakh (net margin 9%) and EBITDA of ₹37.12 Lakh (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 34% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Andromeda Pharmaceuticals Private Limited
CIN U24230MP2011PTC025427
Registration Number 025427
Incorporation Date 21 February 2011
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop Number 3 Medicine Chamber, R.N.T Marg, Indore, Madhya Pradesh, India – 452001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Andromeda Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Andromeda Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Andromeda Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Andromeda Pharmaceuticals Private Limited

The main business activity of Andromeda Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Andromeda Pharmaceuticals Private Limited FY 2025 filings available

Andromeda Pharmaceuticals Private Limited reported revenue of ₹2.69 Cr (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹2.69 Cr ▲ 26%
Net profit · FY 2025
₹24.32 Lakh margin 9%
EBITDA · FY 2025
₹37.12 Lakh margin 13.8%

Compounded Annual Growth Rate (CAGR) of Andromeda Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 38%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 78%
5 years · compounded
▲ 61%

Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 26% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Andromeda Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹37.12 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹24.32 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Andromeda Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin13.8%••••••••••••••••
Net Profit Margin9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Andromeda Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Gmbell Healthcare (India) Private Limited••••••••••••••••-Ahmedabad, Gujarat, India
Asv Pharmaceuticals Private Limited••••••••••••••••-Bangalore, Karnataka, India
Spark Healthcare Private Limited••••••••••••••••-Lucknow, Uttar Pradesh, India
Bemedica Health Care Limited••••••••••••••••-Ernakulam, Kerala, India
Techmed Pharmaceuticals Private Limited••••••••••••••••-New Delhi, Delhi, India
Andromeda Pharmaceuticals Private Limited this company••••••••••••••••-Indore, Madhya Pradesh, India
Siddharth Medicare Private Limited••••••••••••••••-Patna, Bihar, India
Futurelife Pharmaceuticals Private Limited••••••••••••••••-Vadodara, Gujarat, India
Medicure Formulations Private Limited••••••••••••••••-Thane, Maharashtra, India
Zaria Pharmaceuticals Private Limited••••••••••••••••-Thane, Maharashtra, India
Conset Pharma Private Limited••••••••••••••••-Indore, Madhya Pradesh, India

Peers are the five companies nearest above and the five nearest below Andromeda Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals Private Limited is audited by RAKESH K GOYAL & CO for the financial year 2021.

NameStatusAppointment DateCessation Date
RAKESH K GOYAL & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manoj MundraDirector21 Feb 201115 Years 7 MonthsCurrent
Prem Lata PandeyDirector09 Jun 201511 Years 3 MonthsCurrent
Ruchi ShivhareDirector22 Jul 20242 Years 2 MonthsCurrent
Sonu MehrotraDirector21 Feb 201115 Years 7 MonthsCurrent

Ownership and Shareholding of Andromeda Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Andromeda Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Andromeda Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals Private Limited has 5 board changes on record since 2011: 4 appointments and 1 cessation. The latest: Ruchi Shivhare was appointed as Director on 22 Jul 2024.

AGM
Andromeda Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Andromeda Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Ruchi Shivhare was appointed as Director.
Ceased
Prem Lata Pandey ceased to be Additional Director.
Appointed
Prem Lata Pandey was appointed as Director.
Appointed
Manoj Mundra was appointed as Director.
Appointed
Sonu Mehrotra was appointed as Director.
Incorporation
21 Feb 2011
Andromeda Pharmaceuticals Private Limited was registered on 21 Feb 2011 with Roc Gwalior & aged 15 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Andromeda Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Andromeda Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Andromeda Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAJCA2913L1ZSMadhya PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Andromeda Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Andromeda Pharmaceuticals Private Limited

Andromeda Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 February 2011 (15+ years old) and is registered under CIN U24230MP2011PTC025427.

Andromeda Pharmaceuticals reported revenue of ₹2.69 Cr for FY 2025 (up 26% YoY).

Andromeda Pharmaceuticals has 4 current directors:

Andromeda Pharmaceuticals reported a net profit of ₹24.32 Lakh (net margin 9%) and EBITDA of ₹37.12 Lakh (EBITDA margin 13.8%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Andromeda Pharmaceuticals is 38% over three years and 34% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Andromeda Pharmaceuticals is 23AAJCA2913L1ZS, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Andromeda Pharmaceuticals is U24230MP2011PTC025427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Andromeda Pharmaceuticals was incorporated on 21 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Andromeda Pharmaceuticals by revenue are Gmbell Healthcare (India) Private Limited, Asv Pharmaceuticals Private Limited, Spark Healthcare Private Limited, Bemedica Health Care Limited, Techmed Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Ruchi Shivhare was appointed as Director on 22 Jul 2024. Prem Lata Pandey ceased to be Additional Director on 30 Sep 2017. Prem Lata Pandey was appointed as Director on 09 Jun 2015. Andromeda Pharmaceuticals has 5 board changes on record in total.

The registered office of Andromeda Pharmaceuticals is at Shop Number 3 Medicine Chamber, R.N.T Marg, Indore, Madhya Pradesh, India – 452001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available